Metis TechBio Co., Ltd.

HK$10.99As of Sun 8 Nov 2026, 12:00 UTC
HKEX:7666Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap HK$13.00B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$11
0.96%
(64.98%)
Hold 8|3|10|0|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.10
0.10
0.10
0.11
(1.17%)
2.43%
8.15%
15.30%
Revenue¥M
825.3
844.0
824.6
854.3
5.86%
9.15%
4.18%
3.88%
Peers (US$1.658B)
Cap (US$)
PE
1.713B
—
1.646B
17.38x
1.672B
5.690x
Capital
TTM
5Y
10Y
Leveragex
0.052
0.097
0.104
EBIT/Intx
0.521
0.100
0.129
Own earn%
(148.90)
15.10
13.90
Sh yield%
10.56
31.07
26.86
Owners
Insiders/Inst%
3.16
48.94
Short interest%
2.38
SBC / revenue%
3.18
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
7–16
$1 testx
—
Incr. ROIC%
2